Here’s Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week
Agios Pharmaceuticals (NASDAQ: AGIO) stock rose by 13.8% during the week through Friday morning. It’s a move driven…
Here’s Why Agios Pharmaceuticals Crashed 23% Today
Key Points Agios Pharmaceuticals shares dropped 23% following Novo Nordisk’s trial results. Novo’s etavopivat outperformed Agios’ mitapavit in…